Literature DB >> 19250834

Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.

Werner Klinkhammer1, Henrik Müller, Christoph Globisch, Ilza K Pajeva, Michael Wiese.   

Abstract

The development of new modulators possessing high efficacy, low toxicity and high selectivity is a pivotal approach to overcoming P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in tumour cells. In this study 39 compounds are presented which have been synthesized and pharmacologically investigated in our laboratory. Similarly to the potent 3rd generation MDR modulator tariquidar (XR9576) the compounds contain a tetrahydroisoquinoline-ethyl-phenylamine substructure that, in contrast to XR9576, is connected to a smaller hydrophobic part, thus leading to molecules of lower molecular weight. The connection between the tetrahydroisoquinoline-ethyl-phenylamine substructure and the hydrophobic part was achieved through four different types of linkers: amide, urea, amide-ether and amide-styryl. A number of structural modifications in the hydrophobic part were created. The calcein AM assay served as test system to determine the P-gp transport inhibitory potencies of the compounds. For the amide linker derivatives a structure-activity relationship analysis was performed outlining which structural modifications contributed to the inhibitory potency. The compounds containing a bicyclic hydrophobic part with a particular substituent in a specific orientation were identified as the most potent amide derivatives. Among the urea derivatives the compounds with highest inhibitory potency possessed an ortho-nitro substituent. The conformational analysis revealed that this position enables the formation of a hydrogen bond to the urea linker thus stabilizing the conformation. Regarding the amide-styryl derivatives the elongation of the amide linker seemed to be most decisive for the observed increase in activity. The most promising candidate in the whole library possess an amide-ether linker and an ortho-nitro substituent in the hydrophobic part. This compound inhibites P-gp slightly less than tariquidar and can serve as a lead structure for new potent P-gp modulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250834     DOI: 10.1016/j.bmc.2009.01.072

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

Review 2.  Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.

Authors:  Ilza K Pajeva; Michael Wiese
Journal:  AAPS J       Date:  2009-06-06       Impact factor: 4.009

3.  Determining P-glycoprotein-drug interactions: evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers.

Authors:  Donald L Melchior; Frances J Sharom; Raymond Evers; George E Wright; Joseph W K Chu; Stephen E Wright; Xiaoyan Chu; Jocelyn Yabut
Journal:  J Pharmacol Toxicol Methods       Date:  2012-02-26       Impact factor: 1.950

4.  In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.

Authors:  Changdev G Gadhe; Thirumurthy Madhavan; Gugan Kothandan; Seung Joo Cho
Journal:  BMC Struct Biol       Date:  2011-01-26

5.  Role of ABC transporters in cancer chemotherapy.

Authors:  Yue-Li Sun; Atish Patel; Priyank Kumar; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2012-01-17

6.  Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.

Authors:  Yue-Li Sun; Jun-Jiang Chen; Priyank Kumar; Kang Chen; Kamlesh Sodani; Atish Patel; Yang-Lu Chen; Si-Dong Chen; Wen-Qi Jiang; Zhe-Sheng Chen
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

Review 7.  Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.

Authors:  Rishil J Kathawala; Yi-Jun Wang; Charles R Ashby; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2013-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.